Skip to main content

Table 1 Highlights from proteomic studies of the tumor microenvironment

From: Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers

 

Experimental system

Approach

Key proteins

Tumor ECM

EMT in murine cancer cells [24]

MS of subcellular fractions

Fibronectin, collagens, laminins

 

Metastatic melanoma cells [26]

Secretome MS

Fibronectin, ECM1, SPARC, osteopontin

 

Hepatocarcinogenesis [29]

ECM MS

Collagen splice variants, nidogen, decorin, perlecan

 

Cell attachment to collagen [34]

Phosphoprotein analysis

DBF4, GRK6, PAK2, FAK/ PTK2

 

Breast cancer metastasis [34]

MS

Cystatin-M

 

Tumor invasiveness [41]

Antibody libraries

hsp90α

Tumor-stroma interactions

Tumor versus normal stroma [45]

Laser capture + MS

CapG (actin-regulating protein)

 

CAFs [49]

MS of cell lysates

Caveolin-1

 

MMP7 effect of CAFs [50]

MS of cell lysates

IGFBP5

 

Lung cancer TME [54]

Cytokine assays

CXCL1, IL-18

 

Stromal cell secretome [60]

Antibody arrays

HGF

Immune cells in the tumor microenvironment

Mesothelioma effusions [67]

Antibody arrays

HGF, MIP-1d, MIP-3a, NAP-2

 

Ovarian tumor macrophages [68]

MS of supernatants

14-3-3 zeta

 

CD45RA + versus CD45RO + T cells [70]

MS of cell lysates

Cell redox proteins

 

MDSCs + IL1B [72]

MS of cell lysates

FAS pathway and caspase network

  1. Some studies have focused on the ECM, others on tumor-stroma interactions and on immune cells infiltrating the tumor microenvironment. These studies have utilized various experimental systems applied to different tumor types. Some of the key proteins that have been found to be involved are highlighted, illustrating the numerous protein families that play a role in the tumor microenvironment. Abbreviations: CXCL1, interferon-inducible protein-1; DBF4, activator of S-phase kinase 4; GRK6, G-protein coupled receptor kinase 6; FAK, focal adhesion kinase; hsp90α, heat shock protein 90α; IGFBP5, insulin growth factor binding protein 5; IL-18, interleukin-18; IL1B, interleukin1B; MIP-1d, macrophage inflammatory protein-1d; MIP-3a, macrophage inflammatory protein-3a; MMP7, matrix metalloproteinase 7; NAP-2, neutrophil-activating peptide-2; PAK2, SPARC, secreted protein, acidic, cysteine rich; TME, tumor microenvironment.